Symbol="HOWL"
AssetType="Common Stock"
Name="Werewolf Therapeutics Inc"
Description="Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1785530"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1030 MASSACHUSETTS AVENUE, SUITE 210, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="114669000"
EBITDA="-51482000"
PERatio="None"
PEGRatio="None"
BookValue="3.426"
DividendPerShare="0"
DividendYield="0"
EPS="-1.87"
RevenuePerShareTTM="0.679"
ProfitMargin="-2.418"
OperatingMarginTTM="-2.536"
ReturnOnAssetsTTM="-0.184"
ReturnOnEquityTTM="-0.388"
RevenueTTM="20865000"
GrossProfitTTM="-37360000"
DilutedEPSTTM="-1.87"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.06"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.61"
PriceToBookRatio="0.42"
EVToRevenue="0.157"
EVToEBITDA="1.17"
Beta="0.19"
num_52WeekHigh="7.51"
num_52WeekLow="1.39"
num_50DayMovingAverage="2.971"
num_200DayMovingAverage="2.898"
SharesOutstanding="35611400"
DividendDate="None"
ExDividendDate="None"
symbol="HOWL"
open="3.32"
high="3.50"
low="3.14"
price="3.22"
volume="25719.00"
latest_trading_day="2023-07-11"
previous_close="3.32"
change="-0.10"
change_percent="-3.0120%"
aroon_positive_momentum_days="67"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="46383"
Change_recent_avg="-0.02"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.71"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="503"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_negative_thumbnail_id_2="1102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="693"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_positive_thumbnail_id_2="666"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
